| pHreeCOAT™ coatings are |
 |
| pH modulated |
|
| pHreeCOAT™'s patent pending composition modulates surface pH and thus prevents the deposition of seed crystals. The buffering action of pHreeCOAT™ is designed to work in all physiological environments. |
|
| Encrustation resistant |
|
| Substrates coated with pHreeCOAT™ resist encrustation even after four weeks in urine. |
|
| Aqueous |
|
| pHreeCOAT™, as part of the BioLAST family of coatings, contains no organic solvents. Safer and cleaner manufacturing processes are used and any concerns about residual solvents in a device are eliminated. |
|
| Biocompatible |
|
| pHreeCOAT™ is biocompatible as evidenced by successfully passing cytotoxicity, systemic injection, and direct hemolysis tests. |
|
| Adherent |
|
| pHreeCOAT™ can be applied to virtually any biomaterial or device with no flaking or delamination. |
|
|
|
|
|
| How does pHreeCOAT™ work? |
 |
pHreeCOAT™ is a new, patent pending anti-encrustation coating in the BioLAST family. It prevents mineral deposition on indwelling medical devices. pHreeCOAT™ can be used in any application where calcification of a device compromises performance, patient comfort or safety. By modulating surface pH and chemistry, pHreeCOAT™ renders the device virtually invisible to the calcification process. |
|
|
